Galectin Therapeutics Inc
GALT
Revenue
0.00
0.000.00%
-Assets
9.53M
▼-7.97M▼-45.54%
3 Months ChangeLiabilities
121.79M
▲1.22M▲1.02%
3 Months ChangeFree Cash Flow
-4.02M
▼-1.20M▼-42.31%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-09-09
Form 8-K
ID: 0001140361-24-040509
2024-08-13
Form 8-K
ID: 0001140361-24-036938
2024-08-13
Form 10-Q
ID: 0001140361-24-036937
2024-08-01
Form 8-K
ID: 0001140361-24-035212
2024-05-15
Form 8-K
ID: 0001140361-24-026106
2024-05-15
Form 10-Q
ID: 0001140361-24-026105
2024-03-29
Form 8-K
ID: 0001140361-24-016454
2023-12-11
Form 8-K
ID: 0001140361-23-057155
2023-12-07
Form 8-K
ID: 0001140361-23-056586
2023-11-13
Form 8-K
ID: 0001140361-23-052731